These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38933532)

  • 1. An integrated database of experimentally validated major histocompatibility complex epitopes for antigen-specific cancer therapy.
    Kawakita S; Shen A; Chao CC; Wang Z; Cheng S; Li B; Jiang C
    Antib Ther; 2024 Apr; 7(2):177-186. PubMed ID: 38933532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
    Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
    Front Immunol; 2019; 10():1505. PubMed ID: 31333652
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Schmidt J; Guillaume P; Dojcinovic D; Karbach J; Coukos G; Luescher I
    J Biol Chem; 2017 Jul; 292(28):11840-11849. PubMed ID: 28536262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes.
    Chowell D; Krishna S; Becker PD; Cocita C; Shu J; Tan X; Greenberg PD; Klavinskis LS; Blattman JN; Anderson KS
    Proc Natl Acad Sci U S A; 2015 Apr; 112(14):E1754-62. PubMed ID: 25831525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lost in the crowd: identifying targetable MHC class I neoepitopes for cancer immunotherapy.
    Wilson EA; Anderson KS
    Expert Rev Proteomics; 2018 Dec; 15(12):1065-1077. PubMed ID: 30408427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Highly Effective System for Predicting MHC-II Epitopes With Immunogenicity.
    Xu S; Wang X; Fei C
    Front Oncol; 2022; 12():888556. PubMed ID: 35785204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A large-scale study of peptide features defining immunogenicity of cancer neo-epitopes.
    Wan YR; Koşaloğlu-Yalçın Z; Peters B; Nielsen M
    NAR Cancer; 2024 Mar; 6(1):zcae002. PubMed ID: 38288446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A robust deep learning workflow to predict CD8 + T-cell epitopes.
    Lee CH; Huh J; Buckley PR; Jang M; Pinho MP; Fernandes RA; Antanaviciute A; Simmons A; Koohy H
    Genome Med; 2023 Sep; 15(1):70. PubMed ID: 37705109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and Screening of an Antigen-Derived Peptide Library Displayed on Yeast Cell Surface for CD4+ T Cell Epitope Identification.
    Wen F; Smith MR; Zhao H
    Methods Mol Biol; 2019; 2024():213-234. PubMed ID: 31364052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated assessment of predicted MHC binding and cross-conservation with self reveals patterns of viral camouflage.
    He L; De Groot AS; Gutierrez AH; Martin WD; Moise L; Bailey-Kellogg C
    BMC Bioinformatics; 2014; 15 Suppl 4(Suppl 4):S1. PubMed ID: 25104221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models.
    Lopes A; Bastiancich C; Bausart M; Ligot S; Lambricht L; Vanvarenberg K; Ucakar B; Gallez B; Préat V; Vandermeulen G
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
    Zhao W; Sher X
    PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemplating immunopeptidomes to better predict them.
    Gfeller D; Liu Y; Racle J
    Semin Immunol; 2023 Mar; 66():101708. PubMed ID: 36621290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.
    Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B
    Front Immunol; 2018; 9():1795. PubMed ID: 30127785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLimmuno2: predicting MHC class II antigen immunogenicity through transfer learning.
    Wang G; Wu T; Ning W; Diao K; Sun X; Wang J; Wu C; Chen J; Xu D; Liu XS
    Brief Bioinform; 2023 May; 24(3):. PubMed ID: 36960769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing the effect of peptide-HLA-binding ability on the immunogenicity of potential CD8+ and CD4+ T cell epitopes in a large dataset.
    Wang S; Li J; Chen X; Wang L; Liu W; Wu Y
    Immunol Res; 2016 Aug; 64(4):908-18. PubMed ID: 27094547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
    Schneidman-Duhovny D; Khuri N; Dong GQ; Winter MB; Shifrut E; Friedman N; Craik CS; Pratt KP; Paz P; Aswad F; Sali A
    PLoS One; 2018; 13(11):e0206654. PubMed ID: 30399156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles.
    Molvi Z; Klatt MG; Dao T; Urraca J; Scheinberg DA; O'Reilly RJ
    J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37775115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DeepNetBim: deep learning model for predicting HLA-epitope interactions based on network analysis by harnessing binding and immunogenicity information.
    Yang X; Zhao L; Wei F; Li J
    BMC Bioinformatics; 2021 May; 22(1):231. PubMed ID: 33952199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLAsupE: an integrated database of HLA supertype-specific epitopes to aid in the development of vaccines with broad coverage of the human population.
    Wang S; Guo L; Liu D; Liu W; Wu Y
    BMC Immunol; 2016 Jun; 17(1):17. PubMed ID: 27307005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.